M06.1 identifies adult-onset Still's disease (AOSD), a systemic inflammatory condition characterized by quotidian spiking fevers, evanescent salmon-colored rash, polyarthritis, and systemic involvement including lymphadenopathy and hepatosplenomegaly — distinguished from classical rheumatoid arthritis by its acute febrile systemic onset.
Verified May 8, 2026 · 6 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 10
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M06.1.
Source · Editorial brief grounded in 6 cited references ↓
- Provider must explicitly document 'adult-onset Still's disease' — generic terms like 'systemic arthritis' or 'inflammatory polyarthritis' do not support M06.1 and will default to a less-specific code.
- Record the clinical triad supporting AOSD: quotidian fever pattern, characteristic rash, and polyarthritis — this substantiates the diagnosis under audit and differentiates from other M06 subcategories.
- Document negative or positive rheumatoid factor and anti-CCP results; AOSD is typically seronegative, and seropositivity should prompt provider query before assigning M06.1 over a seropositive RA code.
- Capture all systemic complications as separately documented diagnoses (e.g., hepatosplenomegaly, lymphadenopathy, serositis, macrophage activation syndrome) to support the highest-severity DRG.
- Note the age of disease onset and any prior juvenile diagnosis; if the patient had systemic-onset JIA as a child, provider clarification is required before assigning the adult-onset code.
- Document current disease activity status (active flare vs. remission) and any immunomodulatory or biologic therapy in use — relevant for medical necessity on associated procedure and drug claims.
Related CPT procedures
Procedure codes commonly billed with M06.1. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M06.1 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Assigning M08.20 (juvenile rheumatoid arthritis with systemic onset) instead of M06.1 when the patient is an adult with a new AOSD diagnosis — M06.1 applies to adult-onset presentation regardless of current age.
- Using M06.9 (rheumatoid arthritis, unspecified) or M06.4 (inflammatory polyarthropathy) as a proxy when AOSD is clearly documented — both are less specific and will not accurately represent the condition for DRG or quality reporting.
- Failing to code systemic manifestations separately; M06.1 captures the diagnosis but not complications like macrophage activation syndrome or pericarditis, which require additional codes for full DRG severity.
- Applying M06.1 to a patient under age 15 — the code carries an age edit; pediatric systemic-onset presentations belong under M08.2x.
- Omitting M06.1 on follow-up visits because the condition is 'stable' — AOSD is a chronic condition and should continue to be reported at encounters where it affects management.
Clinical context
Source · Editorial summary grounded in 6 cited references ↓
Adult-onset Still's disease is classified under M06 (Other rheumatoid arthritis) within the inflammatory polyarthropathies section (M05–M14). M06.1 is a single billable code with no laterality or site subclassification — the systemic nature of AOSD makes joint-level specificity inapplicable. Use it when a rheumatologist or treating physician has established an AOSD diagnosis in a patient aged 15 or older; the code carries an age edit restricting it to patients 15–124 years.
Do not confuse M06.1 with M08.20 (juvenile rheumatoid arthritis with systemic onset, unspecified site). The ICD-10-CM index cross-references Still's disease as juvenile (M08.20) with an explicit subterm 'adult-onset' pointing to M06.1. Age and physician-documented diagnosis type are the deciding factors. If the record says 'systemic-onset JIA' in an adult who carried the diagnosis since childhood, query the provider before assigning M06.1.
For DRG assignment, M06.1 maps to MS-DRG v43.0 groups 545 (Connective tissue disorders with MCC), 546 (with CC), or 547 (without CC/MCC). Code any documented complications — macrophage activation syndrome, hepatitis, serositis, or myocarditis — as additional diagnoses to support accurate DRG severity capture. AOSD is classified as a chronic condition indicator, so it is appropriate to carry forward on subsequent encounters.
Inclusion & exclusion notes
Per the official ICD-10-CM Tabular List.
Source · CDC ICD-10-CM Official Tabular List · 2026
Excludes 1 — never code together
- Still's disease NOS (M08.2-)
Sibling codes
Other billable codes under M06 (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 6 cited references ↓
01Does M06.1 require a laterality or site modifier?
02What is the difference between M06.1 and M08.20?
03Can M06.1 be reported on every follow-up visit?
04How does M06.1 affect DRG assignment?
05Should I code macrophage activation syndrome separately when it complicates AOSD?
06What if the provider documents 'systemic rheumatoid arthritis' without explicitly naming Still's disease?
07Is M06.1 valid for an orthopedic practice, or is it rheumatology-only?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M05-M14/M06-/M06.1
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M06.1
- 04icdlist.comhttps://icdlist.com/icd-10/M06.1
- 05unboundmedicine.comhttps://www.unboundmedicine.com/icd/view/ICD-10-CM/907415/all/M06_1___Adult_onset_Still's_disease
- 06cdek.pharmacy.purdue.eduhttps://cdek.pharmacy.purdue.edu/icd10/M06.1/
Mira AI Scribe
Mira's AI scribe captures the documented fever pattern (quotidian spiking), rash description, polyarthritis distribution, and systemic findings (lymphadenopathy, hepatosplenomegaly) from the encounter note, along with serology results (RF, anti-CCP) and any active complications. This prevents downcoding to M06.9 or M06.4 and ensures DRG severity is supported by all documented comorbid manifestations.
See how Mira captures M06.1 documentation